Genome- and epigenome-wide studies of plasma protein biomarkers for Alzheimer's disease implicate TBCA and TREM2 in disease risk. (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/dad2.12280
PubMed Identifier: 35475137
Publication URI: http://europepmc.org/abstract/MED/35475137
Type: Journal Article/Review
Volume: 14
Parent Publication: Alzheimer's & dementia (Amsterdam, Netherlands)
Issue: 1
ISSN: 2352-8729